Clinical Trials Directory

Trials / Completed

CompletedNCT00204451

Human Ovarian Follicular Dynamics and Emergency Contraception

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (planned)
Sponsor
University of Saskatchewan · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The researchers hypothesize that emergency contraception (EC) will initiate the changes associated with atresia or ovulatory failure at all stages of follicular development and that the image attributes associated with atresia will be similar regardless of the diameter of the dominant follicle when ovarian suppression is initiated. Second, changes associated with atresia may be observed, but ovulation of the dominant follicle is unimpeded.

Detailed description

This study is a single-center, randomized, open-label, double-controlled protocol to study the pattern of ovarian follicular growth and regression in two groups of women. The first group will use Plan B, which is a progesterone only OC containing 0.75 levonorgestrel. The second group of women will use the Yuzpe regimen, which uses 50 mg ethinyl estradiol/0.5 mg levonorgestrel pills at different stages of the menstrual follicular cycle.

Conditions

Interventions

TypeNameDescription
DRUG0.75 levonorgestrel
DRUG50 mg ethinyl estradiol/0.5 mg levonorgestrel

Timeline

Start date
2005-07-01
Completion
2006-06-01
First posted
2005-09-20
Last updated
2016-11-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00204451. Inclusion in this directory is not an endorsement.